SCOTUS Denies Review of Dismissal at DOJ’s Request; Circuit Split Remains
The Dorsey Health Law blog team keeps readers up-to-date on relevant topics in the health care industry. In order to do so, the members of the blog team communicate regularly with other practice groups within the firm for applicable updates from client publications. For this post, we would like to thank Dorsey’s Christopher DeLong for last week’s FCA Now blog post:
On June 28, 2021, the United States Supreme Court denied review of a Seventh Circuit decision affirming the Department of Justice (“DOJ”)-requested dismissal of a False Claims Act (“FCA”) suit alleging a drug kickback scheme. Cimznhca LLC v. United States, No. 20-1138, 2021 U.S. LEXIS 3404 (June 28, 2021). As a result, the circuit split regarding the standard that applies to a Government’s motion to dismiss an FCA action remains unresolved.
To continue reading, click here.
